UAE Neurology Devices Market Size

UAE Neurology Devices Market Analysis

The UAE neurology devices market is expected to register a CAGR of 4.8% during the forecast period.

• The COVID-19 pandemic significantly impacted neurology care in UAE during the initial phase, which in turn impacted the usage of neurology devices as well. For instance, according to an article published by Hindawi in August 2021, a study was conducted in Abu Dhabi, UAE, which showed that the patients infected with COVID-19 often presented with neurological manifestations in the form of headache, dizziness, hyposmia, myalgia, peripheral neuropathy, acute cerebrovascular disease, and encephalopathy. The source also stated that neurological involvement could be due to virus-induced brain hypoxia, brain infection, or immune reaction. Thus, the COVID-19 pandemic significantly impacted the market initially; however, as the pandemic has currently subsided, neurology care is going back to normal in the UAE. Hence, the studied market is expected to have stable growth during the forecast period of the study.
• The key factors propelling the growth of the studied market are the increasing burden of neurological disorders, huge investments by private players in neurology devices, and the rising geriatric population in the country.
• The increasing incidence of neurological disorders like brain aneurysms, brain tumors, and epilepsy, among others, is the major factor driving the market growth. For instance, according to an article published by Multidisciplinary Digital Publishing Institute (MDPI) in June 2022, a study was conducted in UAE that stated that a brain aneurysm is a critical condition that mostly affects young adults and may cause life-threatening complications such as brain hemorrhage.
• Furthermore, patients with untreated unruptured aneurysms have 50% excess long-term mortality compared with the general population, and one of the most innovative treatment options for brain aneurysms is the use of a flow-diverting stent (FDS). Thus, the high burden of diseases such as brain aneurysms and the increasing use of neurology devices such as FDS are expected to boost market growth.
• Furthermore, according to an article published by PubMed Central in November 2022, brain and central nervous system cancer was among the most common forms of cancer in the UAE. Thus, the high prevalence of such neurological disorders is expected to enhance the usage of neurological devices. Moreover, as these neurological diseases mostly occur in the elderly population, the rising geriatric population in the country is also expected to enhance market growth.
• Thus, the aforementioned factors, such as the rising prevalence of neurological disorders and the increasing research and development activities, are expected to boost the market growth during the forecast period of the study. However, the high cost of equipment is expected to impede the market growth.